Ascentage Pharma Group International (HKG:6855)
45.26
+1.72 (3.95%)
Mar 6, 2026, 4:08 PM HKT
HKG:6855 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 1,661 | 1,261 | 1,094 | 1,492 | 1,744 | 1,024 |
Cash & Short-Term Investments | 1,661 | 1,261 | 1,094 | 1,492 | 1,744 | 1,024 |
Cash Growth | 51.00% | 15.30% | -26.70% | -14.43% | 70.23% | 16.09% |
Accounts Receivable | 78.36 | 83.14 | 145.89 | 54.36 | 53.97 | - |
Other Receivables | 160.31 | 123.21 | 88.29 | 80.44 | 83.56 | 54.64 |
Total Trade Receivables | 238.68 | 206.35 | 234.18 | 134.8 | 137.53 | 54.64 |
Inventory | 8.59 | 6.6 | 16.17 | 9.45 | 3.93 | - |
Total Current Assets | 1,909 | 1,474 | 1,344 | 1,636 | 1,885 | 1,079 |
Net Property, Plant & Equipment | 871.96 | 905.56 | 957.07 | 1,004 | 844.37 | 477 |
Other Intangible Assets | 70.99 | 76 | 85.45 | 84.3 | 60.41 | 66.41 |
Goodwill | 24.69 | 24.69 | 24.69 | 24.69 | 24.69 | 24.69 |
Long-Term Investments | 37.34 | 33.86 | 18.95 | 18.53 | 27.85 | 31.77 |
Other Long-Term Assets | 132.44 | 103.54 | 70.06 | 62.1 | 97.46 | 52.12 |
Total Assets | 3,046 | 2,618 | 2,500 | 2,830 | 2,940 | 1,731 |
Accounts Payable | 118.68 | 91.97 | 72.45 | 95.56 | 70.86 | 23.36 |
Accrued Expenses | 249.36 | 258.1 | 206.91 | 240.03 | 194.18 | 188.57 |
Short-Term Debt | 833.78 | 779.06 | 616.4 | 518.38 | 49.45 | 50.56 |
Unearned Revenue | 37.49 | 37.49 | 38.41 | 24.35 | 24.36 | 0.04 |
Other Current Liabilities | - | - | - | 2.82 | 22.26 | 13.62 |
Total Current Liabilities | 1,239 | 1,167 | 934.17 | 881.15 | 361.11 | 276.15 |
Long-Term Debt | 882.38 | 889.44 | 1,179 | 1,274 | 1,035 | 479.13 |
Other Long-Term Liabilities | 248.55 | 287.6 | 316.4 | 266.11 | 309.38 | 129.14 |
Total Long-Term Liabilities | 1,131 | 1,177 | 1,496 | 1,540 | 1,344 | 608.27 |
Total Liabilities | 2,370 | 2,344 | 2,430 | 2,422 | 1,705 | 884.42 |
Common Stock | 0.24 | 0.21 | 0.2 | 0.18 | 0.18 | 0.15 |
Treasury Stock | -2.96 | -0.01 | -21.35 | -26.55 | -0 | -0 |
Additional Paid-in Capital | 7,546 | - | - | - | - | - |
Accumulated Other Comprehensive Income | -516.07 | 263.99 | 81.57 | 435.03 | 1,235 | 846.47 |
Retained Earnings | -6,361 | - | - | - | - | - |
Total Common Shareholders' Equity | 666 | 264.19 | 60.42 | 408.66 | 1,235 | 846.62 |
Minority Interest | 9.91 | 9.97 | 10.22 | - | - | - |
Shareholders' Equity | 675.91 | 274.16 | 70.63 | 408.66 | 1,235 | 846.62 |
Total Liabilities & Equity | 3,046 | 2,618 | 2,500 | 2,830 | 2,940 | 1,731 |
Total Debt | 1,716 | 1,668 | 1,796 | 1,793 | 1,084 | 529.7 |
Net Cash (Debt) | -54.71 | -407.29 | -701.76 | -300.49 | 659.53 | 494.71 |
Net Cash Growth | - | - | - | - | 33.32% | -36.66% |
Net Cash Per Share | -0.67 | -5.39 | - | -4.56 | 10.36 | 9.16 |
Book Value | 666 | 264.19 | 60.42 | 408.66 | 1,235 | 846.62 |
Book Value Per Share | 8.20 | 3.50 | - | 6.20 | 19.40 | 15.68 |
Tangible Book Value | 570.31 | 163.5 | -49.72 | 299.66 | 1,150 | 755.52 |
Tangible Book Value Per Share | 7.02 | 2.17 | - | 4.55 | 18.06 | 14.00 |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.